A new study has shown significant increases in survival for several types of advanced cancer after treatment with anti-PD-1 therapy nivolumab.
Anti-PD-1 Drug Nivolumab Significantly Improves Five Year Survival In Advanced Cancers
A new study has shown significant increases in survival for several types of advanced cancer after treatment with anti-PD-1 therapy nivolumab.